Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Anasetti

Showing results (141-150 of 222) with videos related to

Pageof 23
Sort By:
Blood|August 1, 1994
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemiaR Storb, R Etzioni, C Anasetti, et al.
Blood|March 1, 1997
Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donorsE W Petersdorf, G M Longton, C Anasetti, et al.
Annals of Internal Medicine|April 15, 1990
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcomeF R Appelbaum, J Barrall, R Storb, et al.
Blood|July 15, 1992
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemiaR Storb, M Pepe, H J Deeg, et al.
Transplantation|July 1, 1990
A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host diseaseC Anasetti, P J Martin, J A Hansen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host diseaseF Carnevale-Schianca, P Martin, K Sullivan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1987
Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16)C Anasetti, P J Martin, C H June, et al.
Blood|August 15, 1991
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow graftsR Storb, J E Sanders, M Pepe, et al.
Transplantation|September 15, 1996
A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host diseaseP L McCarthy, L Williams, M Harris-Bacile, et al.
Blood|June 1, 1992
Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemiaR Storb, P Martin, H J Deeg, et al.
Pageof 23

Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
Blood|August 1, 1994
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemiaR Storb, R Etzioni, C Anasetti, et al.
Blood|March 1, 1997
Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donorsE W Petersdorf, G M Longton, C Anasetti, et al.
Annals of Internal Medicine|April 15, 1990
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcomeF R Appelbaum, J Barrall, R Storb, et al.
Blood|July 15, 1992
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemiaR Storb, M Pepe, H J Deeg, et al.
Transplantation|July 1, 1990
A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host diseaseC Anasetti, P J Martin, J A Hansen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host diseaseF Carnevale-Schianca, P Martin, K Sullivan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1987
Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16)C Anasetti, P J Martin, C H June, et al.
Blood|August 15, 1991
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow graftsR Storb, J E Sanders, M Pepe, et al.
Transplantation|September 15, 1996
A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host diseaseP L McCarthy, L Williams, M Harris-Bacile, et al.
Blood|June 1, 1992
Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemiaR Storb, P Martin, H J Deeg, et al.
Pageof 23